WDA
TMO icon

Wendell David Associates’s Thermo Fisher Scientific TMO Stock Holding History

Wendell David Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
2,087
-370
-15% -$178K 0.11% 91
2026
Q1 		$1.21M Sell
2,457
-5
-0.2% -$2.71K 0.13% 84
2025
Q4 		$1.43M Sell
2,462
-115
-4% -$65K 0.15% 78
2025
Q3 		$1.25M Sell
2,577
-104
-4% -$48.4K 0.12% 82
2025
Q2 		$1.09M Sell
2,681
-278
-9% -$116K 0.11% 88
2025
Q1 		$1.47M Sell
2,959
-1,247
-30% -$675K 0.15% 77
2024
Q4 		$2.19M Sell
4,206
-90
-2% -$49.5K 0.22% 68
2024
Q3 		$2.66M Buy
4,296
+176
+4% +$104K 0.25% 64
2024
Q2 		$2.28M Buy
4,120
+33
+0.8% +$18.9K 0.23% 68
2024
Q1 		$2.38M Sell
4,087
-26
-0.6% -$14.6K 0.24% 71
2023
Q4 		$2.18M Sell
4,113
-134
-3% -$64.9K 0.24% 71
2023
Q3 		$2.15M Buy
4,247
+673
+19% +$359K 0.25% 70
2023
Q2 		$1.86M Buy
3,574
+309
+9% +$167K 0.21% 76
2023
Q1 		$1.88M Buy
3,265
+135
+4% +$76.1K 0.22% 76
2022
Q4 		$1.72M Sell
3,130
-14
-0.4% -$7.42K 0.21% 75
2022
Q3 		$1.59M Buy
3,144
+25
+0.8% +$14K 0.21% 73
2022
Q2 		$1.69M Buy
3,119
+95
+3% +$52.3K 0.22% 73
2022
Q1 		$1.79M Buy
3,024
+314
+12% +$180K 0.2% 76
2021
Q4 		$1.81M Buy
2,710
+1,205
+80% +$752K 0.18% 78
2021
Q3 		$860K Buy
1,505
+140
+10% +$76.8K 0.1% 95
2021
Q2 		$689K Buy
1,365
+23
+2% +$10.9K 0.08% 103
2021
Q1 		$612K Buy
1,342
+27
+2% +$12.9K 0.07% 101
2020
Q4 		$613K Sell
1,315
-14
-1% -$6.56K 0.08% 101
2020
Q3 		$587K Hold
1,329
– – 0.08% 99
2020
Q2 		$482K Hold
1,329
– – 0.07% 106
2020
Q1 		$377K Hold
1,329
– – 0.06% 114
2019
Q4 		$432K Sell
1,329
-20
-1% -$6.06K 0.06% 118
2019
Q3 		$393K Hold
1,349
– – 0.06% 121
2019
Q2 		$396K Hold
1,349
– – 0.06% 123
2019
Q1 		$369K Buy
1,349
+313
+30% +$77.9K 0.06% 126
2018
Q4 		$232K Buy
1,036
+130
+14% +$30.5K 0.04% 135
2018
Q3 		$221K Buy
+906
New +$208K 0.03% 149

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Wendell David Associates's TMO Position: Q2 2026 in Review

Wendell David Associates reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q2 2026, selling an estimated $178K and leaving 2,087 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #91.

Wendell David Associates first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $2.66M in Q3 2024. 954 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wendell David Associates held 2,087 shares of Thermo Fisher Scientific worth $1.05M as of Q2 2026.
  • Wendell David Associates sold 370 Thermo Fisher Scientific shares in Q2 2026, an estimated $178K.
  • Thermo Fisher Scientific made up 0.11% of Wendell David Associates's portfolio in Q2 2026, its #91 holding.
  • Wendell David Associates first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
  • Wendell David Associates's Thermo Fisher Scientific position peaked at $2.66M in Q3 2024.
  • 954 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.